New method for ophthalmic delivery of azithromycin by poloxamer/carbopol- based in situ gelling system

Drug Delivery

Volumn 17, Issue 7, 2010, Pages 500-507

  Cao, Feng ^a   Zhang, Xiaolin ^a   Ping, Qineng ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Azithromycin; In situ gels; Ocular elimination.; Ophthalmic delivery systems; Thermosensitive systems

Indexed keywords

AZITHROMYCIN; CARBOPOL 974P; EYE DROPS; POLOXAMER;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CONJUNCTIVITIS; CONTROLLED STUDY; DRUG FORMULATION; DRUG HALF LIFE; DRUG SOLUBILITY; DRUG SYNTHESIS; EVALUATION; GELATION; HEAT SENSITIVITY; MAXIMUM PLASMA CONCENTRATION; MINIMUM INHIBITORY CONCENTRATION; MUCOADHESION; NONHUMAN; PRIORITY JOURNAL; RABBIT; VISCOSITY;

ANIMALS; AZITHROMYCIN; BIOLOGICAL AVAILABILITY; CHEMISTRY, PHARMACEUTICAL; CORNEA; DRUG ADMINISTRATION ROUTES; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; EYE; FEMALE; GELS; MALE; OPHTHALMIC SOLUTIONS; POLOXAMER; POLYVINYLS; RABBITS; RHEOLOGY; TEMPERATURE;

EID: 77956148557     PISSN: 10717544     EISSN: 15210464     Source Type: Journal    
DOI: 10.3109/10717544.2010.483255     Document Type: Article

References (32)

1. Alexandridis, P., Hatton, T.A. (1995). Poly(ethylene oxide)- poly(propylene oxide)-poly(propylene oxide)-poly(ethylene oxide) block copolymer surfactants in aqueous solutions and at interfaces: thermodynamic structure, dynamic and modeling. Colloids Surf A. 96:1-46.
2. Amar, T., Caillaud, T., Elena, P.P. (2008). Ocular pharmacokinetic study following single and multiple azithromycin administrations in pigmented rabbits. Curr Eye Res. 33:149-158
3. ® 934)/surfactant interactions in aqueous media. Part I: nonionic surfactants. Int J Pharm. 258:165-177
4. Bothner, H., Waaler, T., Wik, O. (1990). Rheological characterization of tear substitutes. Drug Dev Ind Pharm. 16:755-768
5. Bottari, F., Dicolo, G., Nannipieri, E., Saettone, M.F., Serafni, M.F. (1974). Infuence of drug concentration on in vitro release of salicylic acid from ointment bases. J Pharm Sci. 63:1779-1783
6. Bowman, L.M., Si, E., Pang, J., Archibald, R., Friedlaender, M. (2009). Development of a topical polymeric mucoadhesive ocular delivery system for azithromycin. J Ocul Pharmacol Ter. 25:133-139
7. Bowman, R.J., Sillah, A., Van, D.C., Goode, V.M., Muqit, M.M., Johnson, G.J., Milligan, P., Rowley, J., Faal, H., Bailey, R.L. (2000). Operational comparison of single-dose azithromycin and topical tetracycline for trachoma. Invest Ophthalmol Vis Sci. 41:4074-4079
8. Choi, H., Lee, M., Kim, M., Kim, C. (1998). Efect of additives on the physicochemical properties of liquid suppository bases. Int J Pharm. 190:13-19.
9. Cochereau, I., Goldschmidt, P., Goepogui, A., Afghani, T., Delval, L., Pouliquen, P., Bourcier, T., Robert, P.Y. (2007). Efcacy and safety of short duration azithromycin eye drops versus azithro-mycin single oral dose for the treatment of trachoma in children: a randomised, controlled, doublemasked clinical trial. Br J Ophthalmol. 5:667-672
10. Edsman, K., Carlfors, J., Petersson, R. (1998). Rheological evaluation of poloxamer as an in situ gel for ophthalmic use. Eur J Pharm Sci. 6:105-112
11. El-Kamel, A., Al-Dosari, H., Al-Jenoobi, F. (2006). Environmentally responsive ophthalmic gel formulation of carteolol hydrochlo-ride. Drug Del. 13:55-59
12. Gilbert, J.C., Richardson, J.C., Davies, M.C., Palin, K.J., Hadgraft, J. (1987). The efect of solutes and polymers on the gelation properties of pluronic F-127 solutions for controlled drug delivery. J Contr Rel. 5:113-118
13. Jain, S.P., Shah, S.P., Rajadhyaksha, N.S., Singh, P.S., Amin, P.D. (2008). In situ ophthalmic gel of ciprofoxacin hydrochloride for once a day sustained delivery. Drug Dev Ind Pharm. 34:445-452
14. Kyyronen, K., Urtti, A. (1990). Improved ocular: systemic absorption ratio of timolol by viscous vehicle and phenylephrine. Invest Ophthalmol Vis Sci. 31:1827-1833
15. Lallemand, F., Furrer, P., Felt-Baeyens, O., Gex-Fabry, M., Dumont, J.M., Besseghir, K., Gurny, R. (2005). A novel water-soluble cyclosporine A prodrug: ocular tolerance and in vivo kinetics. Int J Pharm. 295:7-14.
16. Lederer, C.M., Harold, R.E. (1986). Drop size of commercial glaucoma medications. Am J Ophthalmol. 101:691-694
17. Lee, J.W., Park, J.H., Robinson, J.R. (2000). Bioadhesive based dosage forms: the next generation. J Pharm Sci. 89:850-866
18. Lee, V.H., Robinson, J.R. (1979). Mechanistic and quantitative evaluation of precorneal pilocarpine disposition in albino rabbits. J Pharm Sci. 68:673-684
19. Lee, V.H., Robinson, J.R. (1986). Topical ocular drug delivery: recent developments and future challenges. J Ocul Pharmacol. 2:67-108.
20. Lenarets, V., Triqueneaux, C., Quartern, M., Falson, F.R., Couvreur, P. (1987). Temperature-dependent rheological behavior of Pluronic F-127 aqueous solutions. Int J Pharm. 31:121-127
21. Lin, H.R., Sung, K.C. (2000). Carbopol/pluronic phase change solutions for ophthalmic drug delivery. J Contr Rel. 69:379-388
22. Ludwig, A. (2005). The use of mucoadhesive polymers in ocular drug delivery. Adv Drug Deliv Rev. 57:1595-1639
23. Ma, W.D., Xu, H., Nie, S.F., Pan, W.S. (2008). Temperature-responsive, Pluronic-g-poly(acrylic acid) copolymers in situ gels for ophthalmic drug delivery: rheology, in vitro drug release, and in vivo resident property. Drug Dev Ind Pharm. 34:258-266
24. Mansour, M., Mansour, S., Mortada, N.D., Abd Elhady, S.S. (2008). Ocular poloxamer-based ciprofoxacin hydrochloride in situ forming gels. Drug Dev Ind Pharm. 34:744-752
25. Mundada, A.S., Avari, J.G. (2009). In situ gelling polymers in ocular drug delivery systems: a review. Crit Rev Ter Drug Carrier Syst. 26:85-118.
26. Nanjawade, B.K., Manvi, F.V., Manjappa, A.S. (2007). In situ-forming hydrogels for sustained ophthalmic drug delivery. J Contr Rel. 122:119-134
27. Qi, H., Chen, W., Huang, C., Li, L., Chen, C., Li, W., Wu, C. (2007). Development of a poloxamer analogs/carbopol-based in situ gelling and mucoadhesive ophthalmic delivery system for puerarin. Int J Pharm. 337:178-187
28. Sasaki, H., Nagano, T., Sakanaka, K. (2003). One-side-coated insert as a unique ophthalmic drug delivery system. J Contr Rel. 92:241-247
29. Si, E.C., Cheung, P.S., Bowman, L., Hosseini, K. (2009). Ocular phar-macokinetics of AzaSite Xtra\2% azithromycin formulated in a DuraSite delivery system. Curr Eye Res. 34:485-491
30. Singla, A.K., Chawla, M., Singh, A. (2000). Potential applications of carbomer in oral mucoadhesive controlled drug delivery system: a review. Drug Dev Ind Pharm. 26:913-924
31. Tirnaksiz, F., Robinson, J.R. (2005). Rheological, mucoadhesive and release properties of Pluronic F-127 gel and Pluronic F-127/poly-carbophil mixed gel systems. Pharmazie. 60:518-523
32. Wei, G., Xu, H., Ding, P.T., Li, S.M., Zheng, J.M. (2002). Termosetting gels with modulated gelation temperature for ophthalmic use: the rheological and gamma scintigraphic studies. J Contr Rel. 83:65-74.